Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that twelve presentations following expansive research in amyotrophic lateral sclerosis (ALS) will be shared as part of the Northeast ...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of real-world data from a retrospective analysis of healthcare resource utilization (HCRU) among people with amyotrophic ...
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced two presentations at the 2024 National Association of Specialty Pharmacy (NASP) Annual Meeting and expo being held in Nashville, T.N., ...